scholarly journals Application of an Immobilization Device for the Modified Killian’s Method

2021 ◽  
Author(s):  
Kazunori Fujiwara ◽  
Satoshi Koyama ◽  
Ryohei Donishi ◽  
Tsuyoshi Morisaki ◽  
Takahiro Fukuhara ◽  
...  
Radiology ◽  
1964 ◽  
Vol 83 (3) ◽  
pp. 538-539
Author(s):  
Kurt R. Straube

1995 ◽  
Vol 10 (4) ◽  
pp. 232-237 ◽  
Author(s):  
Thomas Manix ◽  
Michael R. Gunderson ◽  
Geoffrey C. Garth

AbstractIntroduction:Previous evaluations of prehospital devices intended for spinal immobilization have focused on the device's ability to restrict motion only. This study defines six relevant criteria for evaluation of cervical immobilization device (CID) performance.Objectives:To suggest relevant criteria for evaluation and use available technology to improve measurements for performance testing of prehospital-care devices.Methods:Six parameters (motion restriction, access, ease of application, environmental performance, radiolucency, and storage size) were used to evaluate three types of CIDs: Device A—a single-use corrugated board; Device B—a reusable foam-block CID; and Device C—hospital towels and adhesive tape. To test motion restriction, the most frequently compared parameters for immobilization devices, 20 volunteers were asked to move their heads and necks through a series of motions (flexion, extension, lateral bending and rotation). Their movements were videotaped, still images of each movement were generated, and the degrees of deflection recorded from these still images. To ensure a consistent level of force, electromyography (EMG) of the sternodydomastoid and extensor muscles was employed.Results:Data were produced for each parameter and presented for comparison. The use of video to determine deflection proved to be a useful and highly accurate (±1°) method for measurement. The use of EMG technology enabled force to be controlled indirectly when the subjects used moderate levels of exertion. Overall, Devices A and C restricted motion better than Device B. Although Device C required the shortest time for application, it took the longest to prepare for application. The total time required for preparation and application of A and B essentially were equivalent, with A requiring no preparation time but taking the longest for application, and B having an intermediate interval for application. Device A allowed for the best examination of the head and neck. No differences were detected in performance in extreme environmental conditions or in radiolucency for cervical spine X-ray examinations. Device A consumed the smallest storage volume, B the greatest storage volume, and C an intermediate volume substantially greater than that required for A.Conclusion:Device evaluation should include examination of all relevant performance parameters using the most accurate and meaningful methods possible.


2012 ◽  
Vol 68 (3) ◽  
pp. 254-259 ◽  
Author(s):  
Yuko Morita ◽  
Shingo Tajiri ◽  
Junichi Sasaki ◽  
Hiroya Shiomi ◽  
Ryoongjin Oh ◽  
...  

2011 ◽  
Vol 29 (27_suppl) ◽  
pp. 116-116
Author(s):  
Z. A. Husain ◽  
S. J. Feigenberg ◽  
E. Nichols ◽  
J. Zhang ◽  
C. Yu ◽  
...  

116 Background: To determine the dosimetric characteristics and risk of breast fibrosis using a normal tissue complication probability (NTCP) model in conjunction with a novel preoperative stereotactic radiotherapy system called the GammaPod. Results are compared with linac based post-lumpectomy APBI plans for the same cohort. Methods: The GammaPod breast SBRT system consists of a Co-60 irradiation unit in combination with an immobilization device with embedded fiducials. Eight patients were enrolled in an IRB-approved protocol and underwent CT scans in the prone position with breast immobilization. A preoperative target (GTV) was synthesized to match the tumor location and volume reported in imaging studies obtained prior to surgery (0.3-2.4 cc). The GTV was expanded by 1.5 cm to create a CTV, and a PTV was created using an additional 0.3 cm margin. The PTV was prescribed 25.5 Gy in 3 fx, which is radiobiologically equivalent to conventional APBI doses of 38.5 Gy in 10 fx. Following the radioablative experience in NSCLC, we also planned to deliver 60.0 Gy to the GTV+0.3 cm as a simultaneous boost in conjunction with the 25.5 Gy PTV prescription dose. For comparison, linac-based treatment plans were created for the same cohort following NSABP B-39 guidelines. Whole breast dosimetry was analyzed in terms of biologically equivalent dose (BED) and Lyman NTCP analysis was performed. Results: The volume of ipsilateral breast receiving 10, 20, 50, and 100% of the prescribed dose was substantially smaller in GammaPod vs. APBI plans, with cohort averages of 19.3, 13.0, 7.1 and 4.0% vs. 75.8, 67.3, 48.1 and 27.6% respectively (p<0.001). Even though the PTV equivalent uniform BED (EUD) was substantially higher in GammaPod plans (87.9 Gy vs. 57.3 Gy), the ipsilateral breast EUD was still smaller in these plans, 18.9 ± 5.0 Gy vs. 47.2 ± 3.2 Gy (p<0.001). Corresponding NTCP predictions for breast fibrosis rates following GammaPod and APBI treatments were 0.2 ± 0.1% vs. 2.8 ± 0.8% (p<0.001), respectively. Conclusions: The GammaPod system improves upon traditional post-lumpectomy linac-based APBI by decreasing dose to the ipsilateral breast as well as the predicted rates of breast fibrosis.


Radiology ◽  
1957 ◽  
Vol 68 (3) ◽  
pp. 419-421 ◽  
Author(s):  
Bernard Roswit ◽  
Cyprian B. Reid ◽  
Stanley J. Malsky

Sign in / Sign up

Export Citation Format

Share Document